Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
- Author:
Sun Young YIM
1
;
Sung Hwan LEE
;
Ji Hoon KIM
;
Sunyoung S LEE
;
Ahmed O KASEB
;
Ju-Seog LEE
Author Information
- Publication Type:Correspondence
- From:Clinical and Molecular Hepatology 2025;31(1):e84-e86
- CountryRepublic of Korea
- Language:English
